- Home
- BLRX vs SMSI Comparison
BLRX vs SMSI Comparison
Compare BLRX & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- SMSI
- Stock Information
- Founded
- BLRX 2003
- SMSI 1982
- Country
- BLRX Israel
- SMSI United States
- Employees
- BLRX N/A
- SMSI N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- BLRX Health Care
- SMSI Technology
- Exchange
- BLRX Nasdaq
- SMSI Nasdaq
- Market Cap
- BLRX 17.0M
- SMSI 16.7M
- IPO Year
- BLRX 2011
- SMSI 1995
- Fundamental
- Price
- BLRX $4.25
- SMSI $0.79
- Analyst Decision
- BLRX Strong Buy
- SMSI Strong Buy
- Analyst Count
- BLRX 2
- SMSI 1
- Target Price
- BLRX $19.00
- SMSI $5.00
- AVG Volume (30 Days)
- BLRX 36.3K
- SMSI 422.4K
- Earning Date
- BLRX 08-14-2025
- SMSI 08-04-2025
- Dividend Yield
- BLRX N/A
- SMSI N/A
- EPS Growth
- BLRX N/A
- SMSI N/A
- EPS
- BLRX N/A
- SMSI N/A
- Revenue
- BLRX $22,340,000.00
- SMSI $19,378,000.00
- Revenue This Year
- BLRX N/A
- SMSI $10.12
- Revenue Next Year
- BLRX N/A
- SMSI $63.12
- P/E Ratio
- BLRX N/A
- SMSI N/A
- Revenue Growth
- BLRX 91.68
- SMSI N/A
- 52 Week Low
- BLRX $2.30
- SMSI $0.52
- 52 Week High
- BLRX $35.60
- SMSI $2.57
- Technical
- Relative Strength Index (RSI)
- BLRX 43.97
- SMSI 40.92
- Support Level
- BLRX $4.47
- SMSI $0.71
- Resistance Level
- BLRX $4.75
- SMSI $1.30
- Average True Range (ATR)
- BLRX 0.30
- SMSI 0.11
- MACD
- BLRX -0.04
- SMSI -0.03
- Stochastic Oscillator
- BLRX 11.96
- SMSI 13.54
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.